InvestorsHub Logo
Followers 8
Posts 1186
Boards Moderated 0
Alias Born 08/28/2004

Re: None

Monday, 04/11/2022 2:35:03 PM

Monday, April 11, 2022 2:35:03 PM

Post# of 1090
This should have been the headline for NRXP months ago, but greed and double-dealing got in the way. (IMO)

Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy

https://www.wallstreetreporter.com/2022/04/11/verus-novel-covid-19-drug-candidate-reduces-deaths-by-55/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News